Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 16, 2026 · Filed Apr 20, 2026
Oracle's Chief Legal Officer sold $2.64M of Oracle shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,642,850
Shares × reported transaction price
37 days after results of Mar 10, 2026, 55 days before results of Jun 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $178.34 on Apr 16, 2026, 45% above its 52-week low and 46% below its high, after a 17% rise over the previous 30 trading days
52-week range $122.82 (Apr 21, 2025) to $328.33 (Sep 10, 2025), 27% of the way up, from 250 adjusted closes. 30 trading days earlier: $152.37 on Mar 4, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Mar 27, 2026 in the U.S. District Court, M.D. Tennessee. A filing is an allegation, not a finding.
2 such cases were open. Jackson County Employees Retirement System v. Oracle Corporation, docket 3:26-cv-00365, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -8.4% | +1.1% | -9.5% |
| 30 days | +4.8% | +5.5% | -0.7% |
| 90 days | -33.0% | +5.4% | -38.4% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
4 different filers disclosed ORCL within 90 days. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.